Dr. Robert Orlowski is Chairman, Ad Interim, Director of Myeloma and Professor of Medicine in the Departments of Lymphoma/Myeloma and Professor, Experimental Therapeutics, Division of Cancer Medicine, at the University of Texas M.D. Anderson Cancer Center in Houston, Texas. He is board-certified in internal medicine and medical oncology. Dr. Orlowski has published numerous book chapters, articles and abstracts on cancer therapy, with a focus on the molecular pathogenesis of oncologic disease processes and the mechanisms of action of chemotherapeutics. Dr. Orlowski earned his Ph.D. in molecular biophysics and biochemistry from Yale University and M.D. from the Yale University School of Medicine. He completed his internship and residency in internal medicine at Barnes Hospital at the Washington University in St. Louis School of Medicine.